🇫🇷 LONCASTUXIMAB TESIRINE in France

LONCASTUXIMAB TESIRINE (LONCASTUXIMAB TESIRINE) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Zynlonta
  • Status: approved

LONCASTUXIMAB TESIRINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in France

Frequently asked questions

Is LONCASTUXIMAB TESIRINE approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for LONCASTUXIMAB TESIRINE in France?

Marketing authorisation holder not available in our data.